Hemodynamic effects of a single intravenous application of prostaglandin E1 on patients with chronic heart failure NYHA class II/III;Hamodynamische effekte einer einmaligen intravenosen applikation von prostaglandin E1 bei einem patientenkollektiv mit chronischer herzinsuffizienz im NYHA-stadium II/III

Zeitschrift fur Kardiologie

Volumn 87, Issue 9, 1998, Pages 683-690

  Schrader, N ^a   Erbel, R ^a   Wittlich, N ^b   Banaie, M ^b   Gschossmann, J ^a   Rink, C ^a   Fuchs, J B ^a   Dagres, N ^a   Mohr Kahaly, S ^b   Meyer, J ^b  

^a Abteilung für Innere Medizin   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Congestive heart failure; Contractility; Hemody; Namic effects; Peripheral artery disease; Prostaglandin E1 (PGE1)

Indexed keywords

PLACEBO; PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; HEART CONTRACTION; HEART FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; PULSE RATE; AGED; CHRONIC DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HEMODYNAMICS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ALPROSTADIL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032153044     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050227     Document Type: Article

References (45)

1. 1-bridging to heart transplantation. Eur Heart J 16 (abstract) (Suppl):99
2. 1 infusion in unstable angina: effects on angina frequency and cardiac function. Am Heart J 108 (4):863-868
3. 1 administration in sheep with congestive heart failure. Prostaglandins Leukot Essent Fatty Acids 41 (1):45-9
4. 1-treatment in left ventricular heart failure. Prostaglandins Leukot Essent Fatty Acids 38 (3):177-80
5. 1 on cardiac blood supply and systemic hemodynamics in acute myocardial ischemia. Farmakol Toksikol 52 (1):30-3
6. 1 increases myocardial contractility in the conscious dog. Can J Physiol Pharmacol 62 (12):1505-1510
7. Morgenstern C, Goebel H, Lochner W (1972) Die Beurteilung der Kontraktilität des Herzens. Dtsch Med Wochenschr 97 (41):1563-1568
8. Mason DT (1969) Usefullness and limitations of the rate of rise of intraventricular pressure (dp/dt) in the evaluation of myocardial contractility in man. Am J Cardiol 23 (4):516-527
9. Urbaszek W, Schauer J, Günther K (1979) Zur Interpretation des pulmonalarteriellen Druckes bei ischämischer Herzkrankheit (IHK). Dtsch Gesundheitswesen, S 195-200
10. Yang SS, Bentivoglio LG, Maranhao V (1980) From cardiac catheterization data to hemodynamic parameters. Davis Company, Philadelphia, pp 223-358
11. Saubermann A, Burkhart F (1971) Der diastolische Pulmonalisdruck zur Beurteilung des linksaurikulären Mitteldrucks. Schweiz Med Wochenschr 101 (17): 599-602
12. Holt JP (1956) Estimation of the residual volume of the ventricle of the dogs heart by two indicator dilution technics. Circulation Res 4:187-195
13. Hosie KF (1962) Thermal-dilution technics. Circulation Res 10:491-504
14. 1 - Wirkungen und therapeutische Wirksamkeit. Springer Verlag, Berlin, S 103-111
15. 1 - Wirkungen und therapeutische Wirksamkeit. Springer Verlag, Berlin, S 133-143
16. Nach den Angaben des Herstellers Schwarz Pharma in der Produktinformation
17. 1 on aggregation of blood platelets in man. Life Sci 7 (1):85-90
18. 1 on platelet behaviour in vitro and in vivo. Brit Med J 2 (550):468-472
19. 1 on platelet function in vitro and in vivo. Brit J Haematol 19 (5):559-571
20. 1 in Atherosclerosis. Springer Verlag, Berlin, pp 49-53
21. 2 on the human erythrocyte as monitored by spin labels. Biochem Biophys Res Comm 56 (2):478-483
22. 1 infusion regimes. In: Sinzinger H, Schrör K (eds) Prostaglandins Clin Biol Res. Alan Liss Inc., New York. 242, pp 365-373
23. 1 analog OP-1206. In: Sinzinger H, Schrör K (eds) Prostaglandins Clin Biol Res. Alan Liss Inc, New York 242, pp 317-322
24. Lucchesi BR, Mullane KM (1986) Leucocytes and ischaemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 26:201-224
25. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67 (5):1016-1023
26. 1 am Ischämiemodell. Klin Wochenschrift 64 (Suppl):257
27. 2 on myocardial infarct size after coronary occlusion in conscious dogs. Circulation Res 49 (3):685-700
28. 1 decreases activation of arterial smooth muscle cells. Lancet 2 (8499): 156-157
29. 1 on smooth muscle cell proliferation. In: Sinzinger H, Schrör K (eds) Prostaglandins Clin Biol Res. Alan Liss Inc, New York 242, pp 351-355
30. 1 in Atherosclerosis. Springer Verlag, Berlin, pp 39-48
31. 1 reduces collagen and glycosaminglycan synthesis in rabbit aorta. Exp Pathol 33 (2):119-122
32. Stary MC, McMillan GG (1983) Kinetics of cell proliferation in experimental atherosclerosis. Arch Path 89:173-178
33. 1 in Atherosclerosis. Springer Verlag, Berlin, pp 32-38
34. Smith DL, Willis AL, Mahmud I (1984) Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis. Prostaglandins Leukot Med 16 (1):1-10
35. 1 to streptokinase improves thrombolysis and leftventricular function in acute myocardial infarction. J Am Coll Cardiol 11 (2 Suppl A):104A
36. 1 plus streptokinase in acute myocardial infarction. Am J Cardiol 58 (13):1161-1166
37. 1-Wirkungen und therapeutische Wirksamkeit. Springer Verlag, Berlin, S 34-44
38. 1 on fractional distribution of cardiac output and organ blood flow in man: a simultaneous and non-invasive determination using double dose thallium-201 scintigraphy. Cardiovasc Res 18 (11):657-662
39. 1 in severe left ventricular failure due to chronic coronary heart disease. Am Heart J 102 (4):703-709
40. 1 infusion in patients with acute myocardial infarction and left ventricular failure. Am Heart J 103 (4):485-489
41. 1 in severe peripheral vascular diseases. Lancet 1 (795):155-156
42. 1 - Wirkungen und therapeutische Wirksamkeit. Springer Verlag, Berlin, S 45-54
43. 1 infusion improves the hemodynamic state in advanced congestive heart failure and reduces elevated ANP-levels. J Cardiothorac Anesth 4 (6) (Suppl 3):95
44. 1 in severe dilated cardiomyopathy. Clin Pharmacol Therap 53 (2):203
45. 1 - Wirkungen und therapeutische Wirksamkeit. Springer Verlag, Berlin, S 133-143